Related Experiment Video
Updated: Dec 24, 2025

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
Development of Sustained-Release Ophthalmic Formulation Based on Tranilast Solid Nanoparticles
Misa Minami1, Ryotaro Seiriki1, Hiroko Otake1
1Faculty of Pharmacy, Kindai University, 3-4-1 Kowakae, Higashi-Osaka, Osaka 577-8502, Japan.
Researchers developed a sustained-release drug delivery system (DDS) using Tranilast (TL) nanoparticles in a gel formulation. This novel approach enhances TL solubility and ocular surface drug duration for improved anti-allergic conjunctivitis treatment.
Area of Science:
- Ophthalmology
- Materials Science
- Nanotechnology
Background:
- Traditional eye drops for allergic conjunctivitis have low bioavailability due to limited conjunctival sac volume and short ocular surface residence time.
- Tranilast (TL) is an anti-allergic agent used in ophthalmic formulations, but its effectiveness is limited by poor bioavailability.
- There is a need for improved drug delivery systems to enhance the efficacy and duration of ophthalmic drugs like TL.
Purpose of the Study:
- To design and evaluate a sustained-release drug delivery system (DDS) for Tranilast (TL) nanoparticles.
- To improve the solubility, stability, and ocular surface residence time of TL.
- To investigate the potential of TL nanoparticles in a gel formulation for enhanced ophthalmic drug delivery.
Main Methods:
- Tranilast (TL) nanoparticles were prepared using bead mill treatment.
- Gel formulations containing TL nanoparticles (TL-NPs-Gel) were created using carboxypolymethylene.
- Particle size, solubility, photo/thermal stability, and drug release profiles of TL-NPs-Gel were analyzed.
- In vitro release studies were conducted to determine the sustained release over time.
Main Results:
- TL nanoparticles (50-100 nm) were successfully prepared and formulated into a gel.
- TL solubility in nanoparticle gel formulations was 5.3-fold higher than in microparticle gel formulations.
- TL-NPs-Gel exhibited enhanced photo and thermal stability compared to dissolved TL.
- Sustained release of TL from TL-NPs-Gel was observed over 180 minutes.
Conclusions:
- The developed TL nanoparticle gel formulation represents a promising sustained-release DDS for ophthalmic applications.
- This DDS significantly improves TL solubility and stability, potentially leading to enhanced therapeutic outcomes for allergic conjunctivitis.
- The findings support the development of nanoparticle-based drug delivery systems for prolonged drug action on the ocular surface.
More Related Videos
07:49Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
Published on: September 17, 2014
07:12Spatio-Temporal In Vivo Imaging of Ocular Drug Delivery Systems using Fiberoptic Confocal Laser Microendoscopy
Published on: September 27, 2021
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence